Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Highlights
RMD logo

ResMed Achieves 9% Revenue Growth and Margin Expansion in Home Care Push

RMD10-QFiling Date: 10/31/2025
ResMed Inc.
Description

What this story covers

ResMed reported 1.3 billion dollars revenue, up 9 percent, driven by sleep devices and software amid home care trends. Margins rose to 61 point 5 percent via efficiencies; cash flow hit 457 million dollars. Strategy emphasizes innovation, acquisitions; legal risks managed. Liquidity strong at 1.4 billion dollars cash, supporting dividends and buybacks.

Story snapshot

CompanyResMed Inc.
TickerRMD
VariantStandard detailed
Duration10:20
Filing type10-Q
PeriodQ1 2025
IndustryHealthcare & Pharmaceuticals
Accession0000943819-25-000090

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in